Home hospital care through telehealth during COVID-19 pandemic in Nepal

DOI: https://doi.org/10.46405/ejms.v4i1.375
Keywords: COVID-19, global health, home hospital, telemedicine, telehealth

Abstract

COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2 has been occurring in waves due to emergence of different strains. During second wave of COVID pandemic in Nepal, largely caused by Delta variant, due to rapid rise in cases, existing hospitals and health facilities were overwhelmed. As a result, telemedicine was expanded to help reduce strain on the healthcare system and meet unusually high demands. A team of physicians with the support from the local government provided hospital level care for patients at home in rural district of Dang in Nepal. This research analyzes implementation of this model of care and outcomes based on review of patient records and treatment guidelines. Within a month, from May 5 to June 13, 2021, a total of 102 patients received care at home. While most patients had mild to moderate disease, 12.8% of patients had severe disease. Telemedicine usage was highest among the 40-59 years age group, with overall recovery rate of 85.3%. The patient satisfaction survey revealed that majority, 86.5% were happy with the medical care they received. This home hospital care model has shown excellent clinical outcomes and high patient satisfaction even in resource limited setting.

References

World Health Organization. Nepal: WHO Coronavirus Disease (COVID-19) Dashboard with Vaccination Data [Internet]. 2021 [cited 2021 May 28]. Available from: https://covid19.who.int/region/searo/country/np

Dhital K. Nepal Covid-19 impact worse than official figures: Only hospital deaths are counted, without testing daily caseload total is meaningless. Nepali Times [Internet]. 2021 May 30 [cited 2021 Jun 13]; Available from: https://www.nepalitimes.com/latest/nepal-covid-19-impact-worse-than-official-figures/

Ministry of Health and Population, Nepal. CoVid19-Dashboard [Internet]. 2021 [cited 2021 May 28]. Available from: https://covid19.mohp.gov.np/

World Health Organization. COVID-19 Clinical management: living guidance [Internet]. Geneva: World Health Organization; 2021 Jan [cited 2021 May 27] p. 81. Available from: https://apps.who.int/iris/handle/10665/338882

Nepal Medical Council COVID-19 Treatment Guidance Committee. Interim Clinical Guidance For Care of Patients with COVID-19 in Healthcare Settings [Internet]. Kathmandu: Nepal Medical Council; 2020 Oct p. 47. Available from: https://nmc.org.np/files/4/NMC%20Clinical%20Guidance%20Update%20%202_Oct_21_2020.pdf

Nepal Government Ministry of Health and Population. COVID Hospital [Internet]. [cited 2021 Jun 18]. Available from: https://covid19.mohp.gov.np/hospital/covid_hospital.html

Car J, Koh GC, Foong PS, Wang CJ. Video consultations in primary and specialist care during the covid-19 pandemic and beyond. BMJ. 2020 Oct 20;371:m3945. doi: 10.1136/bmj.m3945. PMID: 33082127.

Hollander JE, Carr BG. Virtually Perfect? Telemedicine for Covid-19. New England Journal of Medicine. 2020; 382(18), 1679-1681. https://doi.org/10.1056/NEJMp2003539

Internet penetration rate in Nepal from 2010 to 2019 [Internet]. Statista. 2021 [cited 2021 Jun 10]. Available from: https://www.statista.com/statistics/765517/internet-penetration-rate-nepal/

Bhatta R, Aryal K, Ellingsen G. Opportunities and challenges of a rural-telemedicine program in Nepal. J Nepal Health Res Counc. 2015;13(30):149–53. PMID: 26744201.

Published
2022-03-05
How to Cite
1.
Devkota A, Pandey S, Pandey Y, Neupane H, Basnet AK, Shah A, Thakur R, Sah S, Chaudhary D, Mahato A, Acharya S, Paudel P, Pathak A, Acharya Y. Home hospital care through telehealth during COVID-19 pandemic in Nepal. Europasian J Med Sci. [Internet]. 2022Mar.5 [cited 2024May15];4(1). Available from: https://www.europasianjournals.org/ejms/index.php/ejms/article/view/375
Issue
Vol 4 No 1 (2022): EJMS | Issue 7
Section
Brief Communication

Copyright (c) 2022 Authors

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All articles published in EJMS are licensed under the Creative Commons Attribution 4.0 International License (CC-BY 4.0). The author(s) as the copyright holder will retain the ownership of the copyrights without any restrictions for their content under the CC-BY 4.0 license, and allow others to copy, use, print, share, modify, and distribute the content of the article even in commercial purpose as long as the original authors and the journal are properly cited. No permission is required from the author/s or the publishers. Appropriate attribution can be provided by simply citing the original article.

On behalf of all the authors, the corresponding author is responsible for completing and returning the agreement form to the editorial office. More information about the terms and conditions, privacy policies, and copyrights can be found on the webpage of the Creative Commons license privacy policy. https://creativecommons.org/licenses/by/4.0/